Hospital Injectable Products · LP-206
Water for injection Injection
Generic medicine development record. Review the proposed presentation and the professional reference information below.
Development record
- Portfolio reference
- LP-206Hospital Injectable Products
- Generic identity
- Water for injectionInjection
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Ingredient reference
Record identity and reference background.
- Portfolio reference
- LP-206
- Generic ingredient
- Water for injection
- Dosage form
- Injection
- Proposed strength
- 5 mL ampoule; 10 mL ampoule; 20 mL ampoule
- Proposed pack
- Ampoule; carton 100 ampoules
- Portfolio category
- Hospital Injectable Products
About Water for injection
Water for injection is a pharmaceutical preparation used as an appropriate solvent or diluent when an injectable medicine’s authorized instructions require it. A small sterile container is not a medicine for intravenous hydration by itself. Its intended use depends on the receiving medicine and the final preparation, including osmotic and compatibility requirements. It must be clearly distinguished from ordinary drinking water, irrigation water and bacteriostatic preparations.
How to read this profile
Scientific information relates to the ingredient and dosage-form context. It is not approved Luang Pharma labelling, a clinical recommendation, or evidence of equivalence to a referenced product. Multiple strengths or presentations represent separate proposed variants and must not be treated as interchangeable.
02 · Professional background
Scientific & clinical reference
Read the clinical context, selected safety considerations and presentation-specific information below.
Clinical context and therapeutic role
Pharmacy and clinical teams use a specified diluent as part of a validated preparation process. The active medicine determines which diluent, container and final formulation are suitable. Choosing water solely because it appears chemically simple can create a serious error. This catalogue does not prescribe reconstitution volumes or permit substitution for saline, bacteriostatic water or any other product. Exact labeling and aseptic procedures govern its use.
Important safety considerations
Sterile water must not be given intravenously by itself because its lack of solutes can cause haemolysis. Contamination, incorrect dilution and incompatibility with the receiving medicine can also cause harm. Single-use and preservative status must be verified from the actual container. A clear liquid appearance is not proof of sterility. Avoid retaining opened containers or reusing residual contents contrary to the authorized instructions.
These are selected considerations, not a complete list. Use the current instructions or approved label for the exact authorised product and seek appropriate professional advice.
Presentation, handling and storage
The source lists ampoules of several volumes. Confirm that the presentation is specifically sterile water for injection and verify preservative status, container integrity and authorized use. Volume alone does not establish that it suits a particular reconstitution task.
Professional preparation must follow the authorized label and local aseptic procedures. Confirm the correct container, concentration, route and expiry before use. Storage, transport, dilution compatibility and any period after opening or reconstitution require product-specific evidence; this page does not establish them.
Final composition, instructions, shelf life and storage conditions are not established by this portfolio entry. They must come from the controlled documentation for the specific product.
Points for professional review
Confirm the receiving medicine’s diluent requirement and the final preparation specification. Use trained personnel, aseptic technique and the exact labels of both components.
03 · Product enquiry
Documentation & regulatory status
Evidence status
What is established — and what remains open
This record has received an editorial evidence-layer review. The review separates catalogue facts from unresolved product-specific fields and external context; it is not medical, regulatory or market-authorisation approval.
Layer 01
Controlled catalogue facts
- Generic ingredient
- Water for injection
- Dosage form / presentation
- Injection
- Catalogue strength
- 5 mL ampoule; 10 mL ampoule; 20 mL ampoule
- Catalogue pack
- Ampoule; carton 100 ampoules
- Portfolio category
- Hospital Injectable Products
Layer 02
Unresolved product-specific fields
- P019 — The field labelled as strength contains only 5 mL, 10 mL and 20 mL ampoule volumes. Those are container/fill presentations, not a medicinal concentration, and must not be represented as three “strengths”.
- The exact grade, intended diluent function, single-dose status, sterility specification and route limitations require the controlled Luang specification and label.
- Approved indication, patient eligibility and dosing or test interpretation are not established by this portfolio record.
- Registration/authorization, manufacturing or site status, supply availability, storage conditions and shelf life remain product- and market-specific evidence items.
Layer 03
Attributed external context
- DailyMed: Sterile Water for Injection — external comparatorgovernment-hosted external product label
These references provide scientific or regulatory context only. They are not Luang Pharma product labelling, registration, manufacturing evidence, equivalence evidence or confirmation of supply.
Layer 04
Documents required to close the record
- Controlled Water for Injection specification and packaging matrix confirming grade/compendial basis, fill volumes, container system, intended diluent use, sterility controls and exact labelled instructions.
- Destination-market authorisation or other lawful supply-route evidence plus the approved label/leaflet, where applicable.
- Product-specific composition/excipient, storage, shelf-life and pack-control documentation.
- Manufacturing-site and supply-status evidence before any public claim of installed capability, registration, availability or equivalence.
For LP-206, identify the destination country, intended professional use, proposed presentation and the role of your organisation. The appropriate supply route and available documentation must be confirmed for that case.
- Confirm the legal entity, manufacturing site and authorised scope for the proposed supply chain.
- Confirm product registration or another lawful route, approved labelling and the applicable destination requirements.
- Request relevant product information, specifications and supporting evidence through the company contact.
- Confirm storage, transport, traceability, complaints and safety-reporting responsibilities before any agreement.
The public catalogue extends beyond the initial planned facility modules. A listing does not mean that the dosage form is installed, qualified or licensed at Boten.
04 · External sources
Sources and further reading
External sources are provided for reference. Their authors do not endorse Luang Pharma, and another product’s authorisation does not transfer to this portfolio record. Source availability and wording can change.
Professional enquiries
Request product-specific evidence for LP-206.
State the exact presentation, organisation, destination and evidence needed. This public record is not an offer of supply.